Secunderabad Healthcare Ltd.
| BSE: 524540 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE930C01016 |
| BSE 00:00 | 04 Mar | Secunderabad Healthcare Ltd |
| NSE 05:30 | 01 Jan | Secunderabad Healthcare Ltd |
| OPEN | 6.17 |
| PREVIOUS CLOSE | 5.99 |
| VOLUME | 309707 |
| 52-Week high | 6.17 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 50 |
| Buy Price | 5.77 |
| Buy Qty | 25.00 |
| Sell Price | 6.10 |
| Sell Qty | 492.00 |
Secunderabad Healthcare Ltd. (SECUNDHEALTH) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 673.20 | -4.05 | -0.60 | 3211.14 |
| Dr Reddy's Labs | 5414.90 | -44.65 | -0.82 | 2937.70 |
| Cipla | 969.60 | -6.60 | -0.68 | 2318.17 |
| Aurobindo Pharma | 993.30 | -1.05 | -0.11 | 1872.74 |
| Cadila Health. | 646.30 | -8.90 | -1.36 | 1412.90 |
| Divi's Lab. | 4312.90 | -74.15 | -1.69 | 1372.71 |
| Glenmark Pharma. | 640.85 | -2.80 | -0.44 | 1354.55 |
| Alkem Lab | 3185.55 | -47.50 | -1.47 | 1264.42 |
| Alembic Pharma | 997.60 | 3.05 | 0.31 | 969.40 |
| Torrent Pharma. | 2925.00 | -54.65 | -1.83 | 938.51 |
| Gland Pharma | 3146.80 | -10.75 | -0.34 | 772.86 |
| Lupin | 1186.65 | -5.95 | -0.50 | 727.55 |
| Ipca Labs. | 2066.20 | -28.30 | -1.35 | 652.46 |
| Abbott India | 16452.15 | 170.65 | 1.05 | 592.93 |
| Fortis Health. | 232.65 | -1.55 | -0.66 | 513.33 |
| Pfizer | 5499.30 | -58.40 | -1.05 | 509.13 |
| Sanofi India | 7749.65 | -64.70 | -0.83 | 477.60 |
| Natco Pharma | 1106.35 | 0.50 | 0.05 | 474.50 |
| Apollo Hospitals | 3298.90 | -52.55 | -1.57 | 470.30 |
| Granules India | 328.50 | -0.60 | -0.18 | 444.07 |
Quick Links for Secunderabad Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
